Drugs / EYED-002
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07619482 | Jun 2026 → Oct 2028 expected | low tension glaucoma | Stanford University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EYED-002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07619482 ↗ |
| Route | Topical | “topical sterile human insulin eye drops (EYED-002)” NCT07619482 ↗ |